Cargando…
Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
BACKGROUND: Since decision making about treatment with disease-modifying drugs (DMDs) for multiple sclerosis (MS) is preference sensitive, shared decision making between patient and healthcare professional should take place. Patient decision aids could support this shared decision making process by...
Autores principales: | Kremer, I. E. H., Jongen, P. J., Evers, S. M. A. A., Hoogervorst, E. L. J., Verhagen, W. I. M., Hiligsmann, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033667/ https://www.ncbi.nlm.nih.gov/pubmed/33836742 http://dx.doi.org/10.1186/s12911-021-01479-w |
Ejemplares similares
-
Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling
por: Kremer, Ingrid E. H., et al.
Publicado: (2016) -
Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model
por: Kremer, Ingrid E. H., et al.
Publicado: (2020) -
Comparison of preferences of healthcare professionals and MS patients for attributes of disease‐modifying drugs: A best‐worst scaling
por: Kremer, Ingrid E. H., et al.
Publicado: (2017) -
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making
por: Stratil, J. M., et al.
Publicado: (2020) -
Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)